High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system.

Journal of Neuro-oncology
Theodore NicolaidesAnuradha Banerjee

Abstract

Atypical Teratoid/Rhabdoid tumors (AT/RT) of the central nervous system are rare but aggressive tumors of childhood. Median survival with surgery and standard chemotherapy is less than 12 months. In an attempt to improve outcome, patients were treated with aggressive surgical resection and multi-agent chemotherapy, followed by high dose chemotherapy with autologous stem cell rescue. Nine consecutive children (median age 21 months) were diagnosed with AT/RT at the University of California San Francisco Childrens Hospital from 1997 to 2007 and treated with this aggressive approach. Diagnosis was confirmed using molecular markers. There are two long-term survivors (78 and 98 months from diagnosis). One additional patient is alive with disease. Three patients died of disease during therapy. Three patients died of disease after therapy was complete. There were no toxic deaths. Two of nine patients treated for AT/RT at our institution with high dose chemotherapy and autologous bone marrow transplant are long-term survivors, suggesting that a subset of patients can be cured with this approach.

References

Jan 1, 1992·Medical and Pediatric Oncology·M Weinblatt, J Kochen
Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C AllenG Rosen
Feb 1, 1995·Journal of Pediatric Hematology/oncology·T A OlsonF B Ruymann
Jan 1, 1995·Journal of Neuro-oncology·L B RorkeJ Biegel
Dec 1, 1995·Cancer·A TorenG Rechavi
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I J DunkelJ L Finlay
Apr 24, 2004·The American Journal of Surgical Pathology·Alexander R JudkinsJaclyn A Biegel
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joanne M HildenJaclyn A Biegel
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tanya M TekautzAmar Gajjar
Mar 11, 2005·The New England Journal of Medicine·Stefan RutkowskiJoachim Kuehl
Oct 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Russell GeyerUNKNOWN Children's Cancer Group
Jul 21, 2006·Journal of Neuro-oncology·Sarah E SquireKaren J Marcus
Apr 21, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J D'cunjaM A Grotzer
May 18, 2007·The Biochemical Journal·Alexandre ArcaroBarbara Fischer
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Dec 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan N ChiMark W Kieran

❮ Previous
Next ❯

Citations

Oct 26, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L Lafay-CousinA Huang
Mar 22, 2012·Pediatric Blood & Cancer·Julia E HeckBeate Ritz
Sep 10, 2015·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Arthur J DiPatriTadanori Tomita
Jan 1, 2015·Journal of Pediatric Hematology/oncology·Abdulrahman AlsultanMohammed Jarrar
Oct 31, 2019·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Rajesh Kumar MeenaDattaraj P Sawarkar
Feb 28, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alyssa T ReddyAnnie Huang
Aug 31, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Jian-Qiang LuVivek Mehta
Jan 24, 2016·Journal of Child Neurology·Kim Kramer
Sep 10, 2020·Frontiers in Oncology·John D PattersonAnaliz Rodriguez
Mar 16, 2017·Journal of Neurosurgery. Pediatrics·Meena ThatikuntaThomas Moriarty
May 11, 2018·Journal of Korean Neurosurgical Society·Elizabeth Anne RichardsonAnnie Huang

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
irradiate
antisense oligonucleotides
total resection

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.